CMS Guidance May Complicate Drug Pricing, Trigger Lawsuits
On May 12, the Centers for Medicare & Medicaid Services issued draft guidance on the Medicare Drug Price Negotiation Program, which sets forth policies that would be implemented for the Initial...To view the full article, register now.
Already a subscriber? Click here to view full article